COMMUNIQUÉS West-GlobeNewswire

Revive Therapeutics Announces FDA Grants Orphan Drug Designation for Cannabidiol in the Treatment of Autoimmune Hepatitis
27/06/2018
TORONTO, June 27, 2018 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (TSX VENTURE:RVV) (OTCQB:RVVTF) (FSE:31R) ("Revive" or the "Company") , a company focused on the research, development and commercialization of novel [...]
Agility Health Announces Management Cease Trade Order Update
27/06/2018
GRAND RAPIDS, Mich., June 27, 2018 (GLOBE NEWSWIRE) -- Agility Health, Inc. (TSXV:AHI) (“ Agility Health ” or the “ Corporation ”), a leading provider of orthotics, prosthetics and foot care services in Canada, is [...]
CORRECTING and REPLACING -- Foamix Announces Dosing of Last Patient in Phase 3 Rosacea Studies for Minocycline Foam FMX103
27/06/2018
Top-line results expected early Q4 2018 In a release issued under the same headline earlier today by Foamix (NASDAQ:FOMX), please note that in the second paragraph of the release, the top-line data announcement should [...]
Florida Hospital Nicholson Center Earns American College of Surgeons Accreditation
27/06/2018
The Nicholson Center becomes the second facility in the state of Florida to receive ACS-AEI designation CELEBRATION, Fla., June 27, 2018 (GLOBE NEWSWIRE) -- The Florida Hospital Nicholson Center , today announces it has [...]
CohBar Added to Russell 2000® Index
27/06/2018
MENLO PARK, Calif., June 27, 2018 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ:CWBR), an innovative biotechnology company developing mitochondria based therapeutics (MBTs) to treat age-related diseases, was added to the US [...]
Choom and Aurora Team Up for Canadian Retail Cannabis -- CFN Media
27/06/2018
SEATTLE, June 27, 2018 (GLOBE NEWSWIRE) -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an article covering [...]
Final patient receives treatment in stem cell clinical trial for severe blood cancers
27/06/2018
MONTREAL, June 27, 2018 (GLOBE NEWSWIRE) -- ExCellThera Inc., a biotechnology company delivering molecules and bioengineering solutions to expand blood stem cells for therapeutic use, announced today the close of its [...]
Devonian Health Group Announces issuance of United States Patent for its Purgenesis™ anti-aging treatment
27/06/2018
QUEBEC CITY, June 27, 2018 (GLOBE NEWSWIRE) -- Devonian Health Group Inc. ("Devonian" or the "Corporation") (TSXv:GSD) today announced that the United State Intellectual Property Office issued a Notice of Allowance for [...]
Groupe Santé Devonian reçoit l’avis d’acceptation pour le brevet américain de son traitement anti-âge Purgenesis(MC)
27/06/2018
QUÉBEC, 27 juin 2018 (GLOBE NEWSWIRE) -- Groupe Santé Devonian inc. (« Devonian » ou la « Société ») (TSXV:GSD) annonçait aujourd’hui avoir reçu un avis d’acceptation de l’Office de la propriété intellectuelle des États [...]
Why Cannabis Companies (and Investors) Should Be Focused On Women, With Exclusive CEO Interview -- CFN Media
27/06/2018
SEATTLE, June 27, 2018 (GLOBE NEWSWIRE) -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, today announced publication of an article and [...]
CV Sciences, Inc. Issues Letter to Shareholders
27/06/2018
LAS VEGAS, June 27, 2018 (GLOBE NEWSWIRE) -- CV Sciences, Inc. , (OTCQB:CVSI) (the "Company," "CV Sciences," "our" or "we"), preeminent manufacturer and distributor of the industry-dominating brand of hemp extract [...]
Hemispherx Opens FDA-Approved Reimbursement Based Expanded Access Treatment Program for ME/CFS to New Enrollees at Approved Clinical Sites in Nevada and North Carolina
27/06/2018
ORLANDO, Fla., June 27, 2018 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE American:HEB) has announced the immediate expansion of its Treatment Protocol/Expanded Access Programs for ME/CFS in the United States, [...]
Ceapro Inc. Announces Publication of Positive Data from Functional Beverage Formulation Study in Journal of Functional Foods
27/06/2018
Study successfully demonstrated the potential use of beta glucan and coenzyme Q10 as nutraceutical ingredients in functional beverages EDMONTON, Alberta, June 27, 2018 (GLOBE NEWSWIRE) -- Ceapro Inc. ( TSXV:CZO) (“ [...]
Stealth Mark Welcomes Sr. Director of Sales
27/06/2018
HOFFMAN ESTATES, IL, June 27, 2018 (GLOBE NEWSWIRE) -- Wellness Center USA, Inc.’s (OTCQB: WCUI) wholly-owned subsidiary, StealthCo, Inc., dba Stealth Mark, is pleased to announce the appointment of Jim Staley as the [...]
International Endeavors Launches Aggressive Advertising Campaign
27/06/2018
TEMECULA, Calif., June 27, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- International Endeavors Corporation launches a major advertising campaign for the Off Grid Grow Laboratory (OGGL). The OGGL is a solution for any [...]
Lexington Biosciences Concludes Initial HeartSentry Clinical Study
27/06/2018
--Company prepares for multicenter pivotal clinical study VANCOUVER, British Columbia, June 27, 2018 (GLOBE NEWSWIRE) -- Lexington Biosciences, Inc. (CSE:LNB) (OTCQB:LXGTF) (the “Company” or “Lexington”), a development- [...]
Maple Leaf Provides a Corporate Update
27/06/2018
CALGARY, Alberta, June 27, 2018 (GLOBE NEWSWIRE) -- Maple Leaf Green World Inc. (“ Maple Leaf ” or the “ Company ”) (NEO:MGW) (OTCQB:MGWFF) is pleased to provide the following update on its British Columbia and Nevada [...]
CTD to Present at National Niemann-Pick Disease Foundation Annual Conference
27/06/2018
Conference brings together families affected by NPC from across the US ALACHUA, Fla., June 27, 2018 (GLOBE NEWSWIRE) -- CTD Holdings, Inc. (OTCQB:CTDH), a clinical stage biotechnology company that develops cyclodextrin- [...]
Anthera Pharmaceuticals Announces Withdrawal of its Nasdaq Hearing Request and Suspension of Trading of its Securities on the NASDAQ Capital Markets
27/06/2018
HAYWARD, Calif., June 27, 2018 (GLOBE NEWSWIRE) -- Anthera Pharmaceuticals, Inc. (Nasdaq:ANTH) (“Anthera” or the “Company”) announced today that it has withdrawn its request for a hearing to appeal the delisting [...]

Pages